Mr. Askew assumed the position of President and CEO of CSA Medical, Inc. in 2004, focusing the company in 2005 on product development, expanding clinical trials, assembling a management team, and positioning the company for a commercial product launch in 2007. Mr. Askew received his MBA from Boston University in 1989 and is a graduate of the University of Michigan where he studied a pre-medical curriculum.

Mr. Schaefer has over sixteen years of executive experience. Mr. Schaefer joined CSA Medical, Inc. full-time in 2006 as CFO and most recently was appointed President with a focus on expanding the growth of the GI business line. Previously, Mr. Schaefer was CEO of Schaefer & Associates, a Maryland-based consulting firm specializing in corporate advisory services for high growth companies where he began serving as a Board Member for CSA Medical. A Certified Public Accountant, he earned his degree in accounting and finance from Drexel University in Philadelphia.

Dr. Burr joined CSA Medical, Inc. in 2008 as the Vice President of Product Development and now serves as the Company’s Chief Technology Officer. Prior to joining CSA Medical, he led cross-functional teams of R&D, marketing, operations, medical, regulatory, service, quality and finance personnel responsible for overall system design specification, implementation and validation of automated molecular diagnostic instruments for Becton Dickinson Diagnostic Systems. Dr. Burr earned his Ph.D. and MS in Mechanical Engineering from the University of Illinois and his BS in Mechanical Engineering from the University of Washington. A distinguished innovator, Dr. Burr currently holds 20 patents.

Mr. Hughen has over twenty years of professional experience in sales and marketing leadership, product management and strategic planning. He has successfully grown businesses in diverse environments including start up, mid-cap and fortune 100 companies. After spending five years with Johnson & Johnson and twelve years with Abbott Diagnostics, Mr. Hughen directed the marketing strategy and operations for the $120M molecular diagnostics business of Becton, Dickinson and Co. Mr. Hughen is a graduate of The Pennsylvania State University with an MBA in Marketing and BS in Environmental Science.

Mr. Duford brings to CSA Medical over 20 years of experience in the global medical device industry. Prior to joining CSA Medical, he served as founder and president of Adeptus BioSciences Management, a consulting firm focused on therapeutic and diagnostic technologies and methods to identify and treat malignant and benign disease. From 2002 until 2006, Mr. Duford was the North American Business Unit Manager for Axcan Pharma, Inc., manufacturers of Photofrin photodynamic therapy (PDT), a drug-device treatment for GI, lung, head and neck, and chest cancers. In this capacity, he built and developed sales and marketing teams who marketed to hospital-based customers the palliative and curative applications of PDT targeting aerodigestive neoplasms. Mr. Duford holds a B.S. in Marketing from Central Connecticut State University.